CYP4Z1 and CYP1B1 were highly expressed in malignant tissues compared to normal controls; expression correlated with higher tumor grade, suggesting their potential role as prognostic biomarkers for recurrence and therapeutic targets. The gene discussed is CYP4Z1; the disease is neoplasm.